Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 22

1.

A risk score for predicting mortality in patients with asymptomatic mild to moderate aortic stenosis.

Holme I, Pedersen TR, Boman K, Egstrup K, Gerdts E, Kesäniemi YA, Malbecq W, Ray S, Rossebø AB, Wachtell K, Willenheimer R, Gohlke-Bärwolf C.

Heart. 2012 Mar;98(5):377-83. doi: 10.1136/heartjnl-2011-300475. Epub 2011 Dec 8.

PMID:
22155702
2.

Outcome of patients with low-gradient "severe" aortic stenosis and preserved ejection fraction.

Jander N, Minners J, Holme I, Gerdts E, Boman K, Brudi P, Chambers JB, Egstrup K, Kesäniemi YA, Malbecq W, Nienaber CA, Ray S, Rossebø A, Pedersen TR, Skjærpe T, Willenheimer R, Wachtell K, Neumann FJ, Gohlke-Bärwolf C.

Circulation. 2011 Mar 1;123(8):887-95. doi: 10.1161/CIRCULATIONAHA.110.983510. Epub 2011 Feb 14. Erratum in: Circulation. 2011 Sep 20;124(12):e336.

3.

Impact of baseline severity of aortic valve stenosis on effect of intensive lipid lowering therapy (from the SEAS study).

Gerdts E, Rossebø AB, Pedersen TR, Boman K, Brudi P, Chambers JB, Egstrup K, Gohlke-Bärwolf C, Holme I, Kesäniemi YA, Malbecq W, Nienaber C, Ray S, Skjærpe T, Wachtell K, Willenheimer R.

Am J Cardiol. 2010 Dec 1;106(11):1634-9. doi: 10.1016/j.amjcard.2010.07.042. Epub 2010 Oct 14.

PMID:
21094366
4.

Observed and predicted reduction of ischemic cardiovascular events in the Simvastatin and Ezetimibe in Aortic Stenosis trial.

Holme I, Boman K, Brudi P, Egstrup K, Gohlke-Baerwolf C, Kesäniemi YA, Malbecq W, Rossebø AB, Wachtell K, Willenheimer R, Pedersen TR.

Am J Cardiol. 2010 Jun 15;105(12):1802-8. doi: 10.1016/j.amjcard.2010.01.363. Epub 2010 Mar 16.

PMID:
20538134
5.

Effects of high-dose versus low-dose losartan on clinical outcomes in patients with heart failure (HEAAL study): a randomised, double-blind trial.

Konstam MA, Neaton JD, Dickstein K, Drexler H, Komajda M, Martinez FA, Riegger GA, Malbecq W, Smith RD, Guptha S, Poole-Wilson PA; HEAAL Investigators.

Lancet. 2009 Nov 28;374(9704):1840-8. doi: 10.1016/S0140-6736(09)61913-9. Epub 2009 Nov 16. Erratum in: Lancet. 2009 Dec 5;374(9705):1888.

PMID:
19922995
6.

Design of the heart failure endpoint evaluation of AII-antagonist losartan (HEAAL) study in patients intolerant to ACE-inhibitor.

Konstam MA, Poole-Wilson PA, Dickstein K, Drexler H, Justice SJ, Komajda M, Malbecq W, Martinez FA, Neaton JD, Riegger GA, Guptha S.

Eur J Heart Fail. 2008 Sep;10(9):899-906. doi: 10.1016/j.ejheart.2008.07.004. Epub 2008 Sep 2.

7.

Intensive lipid lowering with simvastatin and ezetimibe in aortic stenosis.

Rossebø AB, Pedersen TR, Boman K, Brudi P, Chambers JB, Egstrup K, Gerdts E, Gohlke-Bärwolf C, Holme I, Kesäniemi YA, Malbecq W, Nienaber CA, Ray S, Skjaerpe T, Wachtell K, Willenheimer R; SEAS Investigators.

N Engl J Med. 2008 Sep 25;359(13):1343-56. doi: 10.1056/NEJMoa0804602. Epub 2008 Sep 2.

8.

Design and baseline characteristics of the simvastatin and ezetimibe in aortic stenosis (SEAS) study.

Rossebø AB, Pedersen TR, Allen C, Boman K, Chambers J, Egstrup K, Gerdts E, Gohlke-Bärwolf C, Holme I, Kesäniemi VA, Malbecq W, Nienaber C, Ray S, Skjaerpe T, Wachtell K, Willenheimer R.

Am J Cardiol. 2007 Apr 1;99(7):970-3. Epub 2007 Feb 15.

PMID:
17398194
9.

Rofecoxib in the acute treatment of migraine: a randomized controlled clinical trial.

Saper J, Dahlof C, So Y, Tfelt-Hansen P, Malbecq W, Loeys T, Barraclough E, Klipfel M, Lines C, Visser H, Reines S, Yuen E; Rofecoxib Protocol 162 Study Group.

Headache. 2006 Feb;46(2):264-75.

PMID:
16492236
10.

Montelukast for migraine prophylaxis: a randomized, double-blind, placebo-controlled study.

Brandes JL, Visser WH, Farmer MV, Schuhl AL, Malbecq W, Vrijens F, Lines CR, Reines SA; Protocol 125 study group.

Headache. 2004 Jun;44(6):581-6.

PMID:
15186302
11.

Randomized, placebo-controlled trial of rofecoxib in the acute treatment of migraine.

Silberstein S, Tepper S, Brandes J, Diamond M, Goldstein J, Winner P, Venkatraman S, Vrijens F, Malbecq W, Lines C, Visser WH, Reines S, Yuen E.

Neurology. 2004 May 11;62(9):1552-7.

PMID:
15136680
13.

Oral rizatriptan versus oral sumatriptan: a direct comparative study in the acute treatment of migraine. Rizatriptan 030 Study Group.

Tfelt-Hansen P, Teall J, Rodriguez F, Giacovazzo M, Paz J, Malbecq W, Block GA, Reines SA, Visser WH.

Headache. 1998 Nov-Dec;38(10):748-55.

PMID:
11284463
14.

Comparison of rizatriptan and sumatriptan: a reply to O'Quinn et al.

Tfelt-Hansen P, Goldstein J, Malbecq W, Lines C.

Headache. 1999 May;39(5):340-1. No abstract available.

PMID:
11279915
15.

Time-to-event analysis, or who gets better sooner? An emerging concept in headache study methodology.

Allen C, Jiang K, Malbecq W, Goadsby PJ.

Cephalalgia. 1999 Jul;19(6):552-6.

PMID:
10448541
16.

Pharmacokinetics, bioavailability, and safety of montelukast sodium (MK-0476) in healthy males and females.

Cheng H, Leff JA, Amin R, Gertz BJ, De Smet M, Noonan N, Rogers JD, Malbecq W, Meisner D, Somers G.

Pharm Res. 1996 Mar;13(3):445-8.

PMID:
8692739
17.
18.

Comparison of finasteride (Proscar) and Serenoa repens (Permixon) in the inhibition of 5-alpha reductase in healthy male volunteers.

Strauch G, Perles P, Vergult G, Gabriel M, Gibelin B, Cummings S, Malbecq W, Malice MP.

Eur Urol. 1994;26(3):247-52.

PMID:
7805711
19.

Comparison between lovastatin and gemfibrozil in the treatment of primary hypercholesterolemia: the Finnish Multicenter Study.

Tikkanen MJ, Helve E, Jäättelä A, Kaarsalo E, Lehtonen A, Malbecq W, Oksa H, Pääkkönen P, Salmi J, Veharanta T, et al.

Am J Cardiol. 1988 Nov 11;62(15):35J-43J.

PMID:
3055922
20.

Desynchronization of the oral temperature circadian rhythm and intolerance to shift work.

Reinberg A, Andlauer P, De Prins J, Malbecq W, Vieux N, Bourdeleau P.

Nature. 1984 Mar 15-21;308(5956):272-4.

PMID:
6700729

Supplemental Content

Loading ...
Support Center